US Stock MarketDetailed Quotes

SILK Silk Road Medical

Watchlist
  • 27.050
  • -0.030-0.11%
Close Aug 20 16:00 ET
  • 27.050
  • 0.0000.00%
Post 17:13 ET
1.10BMarket Cap-18655P/E (TTM)

Silk Road Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
13.12%51.24M
20.81%48.48M
27.77%177.13M
17.97%47.27M
18.89%44.44M
36.55%45.3M
43.22%40.13M
36.62%138.64M
41.77%40.07M
51.31%37.37M
Operating revenue
13.12%51.24M
20.81%48.48M
27.77%177.13M
17.97%47.27M
18.89%44.44M
36.55%45.3M
43.22%40.13M
36.62%138.64M
41.77%40.07M
51.31%37.37M
Cost of revenue
-2.06%12.74M
-4.33%11.98M
32.14%50.05M
13.56%12.47M
29.46%12.05M
44.30%13M
46.04%12.53M
48.85%37.88M
51.79%10.98M
53.19%9.31M
Gross profit
19.24%38.51M
32.23%36.5M
26.12%127.09M
19.63%34.8M
15.39%32.39M
33.66%32.29M
41.97%27.61M
32.53%100.76M
38.32%29.09M
50.69%28.07M
Operating expense
19.50%55.7M
15.55%51.44M
21.99%186.36M
17.86%49.17M
23.50%46.06M
21.52%46.61M
25.76%44.52M
23.70%152.77M
18.89%41.72M
16.84%37.29M
Selling and administrative expenses
22.29%43.82M
19.64%40.78M
24.69%145.03M
20.26%39.11M
24.94%36.01M
29.35%35.83M
24.96%34.08M
20.68%116.32M
17.85%32.52M
15.06%28.82M
Research and development costs
10.23%11.88M
2.18%10.66M
13.37%41.32M
9.39%10.06M
18.60%10.05M
1.17%10.78M
28.44%10.43M
34.45%36.45M
22.68%9.2M
23.36%8.47M
Operating profit
-20.11%-17.2M
11.69%-14.93M
-13.97%-59.27M
-13.79%-14.37M
-48.18%-13.67M
-0.86%-14.32M
-5.99%-16.91M
-9.56%-52M
10.18%-12.63M
30.58%-9.23M
Net non-operating interest income expense
-17.45%596K
26.26%750K
220.03%3.09M
1,909.09%884K
180.67%885K
179.43%722K
197.54%594K
-10.82%-2.57M
107.11%44K
-85.62%-1.1M
Non-operating interest income
-4.64%2.32M
8.05%2.47M
294.02%9.96M
47.41%2.62M
324.15%2.62M
1,895.08%2.43M
18,958.33%2.29M
1,176.26%2.53M
11,740.00%1.78M
1,369.05%617K
Non-operating interest expense
0.76%1.73M
1.65%1.72M
34.78%6.87M
0.12%1.73M
1.05%1.73M
66.05%1.71M
172.62%1.69M
102.46%5.1M
173.19%1.73M
170.77%1.71M
Other net income (expense)
-103.64%-4K
133.33%48K
201.61%442K
1,803.57%477K
-150.00%-2K
137.29%110K
-24.14%-144K
-1,791.30%-435K
-133.33%-28K
233.33%4K
Special income (charges)
----
----
--0
--0
--0
----
----
---245K
--0
--0
-Less:Other special charges
----
----
----
----
----
----
----
--245K
--0
----
Other non- operating income (expenses)
-103.64%-4K
133.33%48K
332.63%442K
1,803.57%477K
-150.00%-2K
320.00%110K
-24.14%-144K
-726.09%-190K
-133.33%-28K
233.33%4K
Income before tax
-23.13%-16.6M
14.12%-14.14M
-1.33%-55.74M
-3.15%-13.01M
-23.93%-12.79M
12.43%-13.48M
1.31%-16.46M
-10.44%-55.01M
14.15%-12.61M
25.68%-10.32M
Income tax
Net income
-23.13%-16.6M
14.12%-14.14M
-1.33%-55.74M
-3.15%-13.01M
-23.93%-12.79M
12.43%-13.48M
1.31%-16.46M
-10.44%-55.01M
14.15%-12.61M
25.68%-10.32M
Net income continuous Operations
-23.13%-16.6M
14.12%-14.14M
-1.33%-55.74M
-3.15%-13.01M
-23.93%-12.79M
12.43%-13.48M
1.31%-16.46M
-10.44%-55.01M
14.15%-12.61M
25.68%-10.32M
Minority interest income
Net income attributable to the parent company
-23.13%-16.6M
14.12%-14.14M
-1.33%-55.74M
-3.15%-13.01M
-23.93%-12.79M
12.43%-13.48M
1.31%-16.46M
-10.44%-55.01M
14.15%-12.61M
25.68%-10.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-23.13%-16.6M
14.12%-14.14M
-1.33%-55.74M
-3.15%-13.01M
-23.93%-12.79M
12.43%-13.48M
1.31%-16.46M
-10.44%-55.01M
14.15%-12.61M
25.68%-10.32M
Basic earnings per share
-20.00%-0.42
16.28%-0.36
6.49%-1.44
0.00%-0.34
-13.79%-0.33
20.45%-0.35
10.42%-0.43
-6.94%-1.54
19.05%-0.34
27.50%-0.29
Diluted earnings per share
-20.00%-0.42
16.28%-0.36
6.49%-1.44
0.00%-0.34
-13.79%-0.33
20.45%-0.35
10.42%-0.43
-6.94%-1.54
19.05%-0.34
27.50%-0.29
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 13.12%51.24M20.81%48.48M27.77%177.13M17.97%47.27M18.89%44.44M36.55%45.3M43.22%40.13M36.62%138.64M41.77%40.07M51.31%37.37M
Operating revenue 13.12%51.24M20.81%48.48M27.77%177.13M17.97%47.27M18.89%44.44M36.55%45.3M43.22%40.13M36.62%138.64M41.77%40.07M51.31%37.37M
Cost of revenue -2.06%12.74M-4.33%11.98M32.14%50.05M13.56%12.47M29.46%12.05M44.30%13M46.04%12.53M48.85%37.88M51.79%10.98M53.19%9.31M
Gross profit 19.24%38.51M32.23%36.5M26.12%127.09M19.63%34.8M15.39%32.39M33.66%32.29M41.97%27.61M32.53%100.76M38.32%29.09M50.69%28.07M
Operating expense 19.50%55.7M15.55%51.44M21.99%186.36M17.86%49.17M23.50%46.06M21.52%46.61M25.76%44.52M23.70%152.77M18.89%41.72M16.84%37.29M
Selling and administrative expenses 22.29%43.82M19.64%40.78M24.69%145.03M20.26%39.11M24.94%36.01M29.35%35.83M24.96%34.08M20.68%116.32M17.85%32.52M15.06%28.82M
Research and development costs 10.23%11.88M2.18%10.66M13.37%41.32M9.39%10.06M18.60%10.05M1.17%10.78M28.44%10.43M34.45%36.45M22.68%9.2M23.36%8.47M
Operating profit -20.11%-17.2M11.69%-14.93M-13.97%-59.27M-13.79%-14.37M-48.18%-13.67M-0.86%-14.32M-5.99%-16.91M-9.56%-52M10.18%-12.63M30.58%-9.23M
Net non-operating interest income expense -17.45%596K26.26%750K220.03%3.09M1,909.09%884K180.67%885K179.43%722K197.54%594K-10.82%-2.57M107.11%44K-85.62%-1.1M
Non-operating interest income -4.64%2.32M8.05%2.47M294.02%9.96M47.41%2.62M324.15%2.62M1,895.08%2.43M18,958.33%2.29M1,176.26%2.53M11,740.00%1.78M1,369.05%617K
Non-operating interest expense 0.76%1.73M1.65%1.72M34.78%6.87M0.12%1.73M1.05%1.73M66.05%1.71M172.62%1.69M102.46%5.1M173.19%1.73M170.77%1.71M
Other net income (expense) -103.64%-4K133.33%48K201.61%442K1,803.57%477K-150.00%-2K137.29%110K-24.14%-144K-1,791.30%-435K-133.33%-28K233.33%4K
Special income (charges) ----------0--0--0-----------245K--0--0
-Less:Other special charges ------------------------------245K--0----
Other non- operating income (expenses) -103.64%-4K133.33%48K332.63%442K1,803.57%477K-150.00%-2K320.00%110K-24.14%-144K-726.09%-190K-133.33%-28K233.33%4K
Income before tax -23.13%-16.6M14.12%-14.14M-1.33%-55.74M-3.15%-13.01M-23.93%-12.79M12.43%-13.48M1.31%-16.46M-10.44%-55.01M14.15%-12.61M25.68%-10.32M
Income tax
Net income -23.13%-16.6M14.12%-14.14M-1.33%-55.74M-3.15%-13.01M-23.93%-12.79M12.43%-13.48M1.31%-16.46M-10.44%-55.01M14.15%-12.61M25.68%-10.32M
Net income continuous Operations -23.13%-16.6M14.12%-14.14M-1.33%-55.74M-3.15%-13.01M-23.93%-12.79M12.43%-13.48M1.31%-16.46M-10.44%-55.01M14.15%-12.61M25.68%-10.32M
Minority interest income
Net income attributable to the parent company -23.13%-16.6M14.12%-14.14M-1.33%-55.74M-3.15%-13.01M-23.93%-12.79M12.43%-13.48M1.31%-16.46M-10.44%-55.01M14.15%-12.61M25.68%-10.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -23.13%-16.6M14.12%-14.14M-1.33%-55.74M-3.15%-13.01M-23.93%-12.79M12.43%-13.48M1.31%-16.46M-10.44%-55.01M14.15%-12.61M25.68%-10.32M
Basic earnings per share -20.00%-0.4216.28%-0.366.49%-1.440.00%-0.34-13.79%-0.3320.45%-0.3510.42%-0.43-6.94%-1.5419.05%-0.3427.50%-0.29
Diluted earnings per share -20.00%-0.4216.28%-0.366.49%-1.440.00%-0.34-13.79%-0.3320.45%-0.3510.42%-0.43-6.94%-1.5419.05%-0.3427.50%-0.29
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg